Why the study?
Does a phosphorylcholine coated cardiopulmonary bypass circuit improve biocompatibility and reduce thrombus formation in a canine model?
Does a phosphorylcholine coated cardiopulmonary bypass circuit improve biocompatibility and reduce thrombus formation in a canine model?
Phosphorylcholine coating of cardiopulmonary bypass circuits demonstrates promising biocompatibility and resistance to thrombus formation in a canine model.
No takes yet. Share an insight, caveat, or question.
Supports biocompatibility evaluation of phosphorylcholine coatings; leaves open translation to human cardiopulmonary bypass.
Somer et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: